[ Price : $8.95]
CDERs Division of Drug Marketing, Advertising, and Communications warns Tercica about misleading professional promotional material...[ Price : $8.95]
FDA warns Claris Lifesciences on multiple violations found at its Indian and U.S. facilities.[ Price : $8.95]
A federal grand jury indicts former Glaxo attorney Lauren Stevens for lying to FDA about off-label promotion of a drug.[ Price : $8.95]
Federal Register Notice: FDA makes available the status of postmarketing requirements for approved drug and biological products.[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Bioenergy, Claris Lifesciences, CP Pharmaceuticals, and Ipsen Group-Tercica.[ Price : $8.95]
HHS Office of Inspector General closes its second investigation into CDRH misconduct involving allegations of management pressure ...[ Price : $8.95]
New research published in the Journal of the American Medical Association supports development of automated surveillance systems t...[ Price : $8.95]
Santarus plans to file an NDA with FDA in the second half of 2011 due to positive results from a Phase 3 European trial of budeson...